Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5157)	12/19/1997 9:00:00 PM
From: opalapril	Respond to of 17367

Jesus Cristo! You'll never leave your screen again. Came across this in some message board or another. More links than than you'll ever need, want, or are good for you. angelfire.com

To: aknahow who wrote (5157)	12/19/1997 9:13:00 PM
From: opalapril	Read Replies (1) \| Respond to of 17367

Better yet, after a week like this one, loyal XOMANIACS deserve a laugh or two as an antitdote. If slightly vulgar, in-your-face satire makes you laugh, try this: theonion.com (The main honchos at MF once linked to this)

To: aknahow who wrote (5157)	12/19/1997 11:25:00 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

The world according to my interputation.............................................. .....Glossary up by monday GNE money by about jan 1 financing option possible meningo at 117 or so meningo may get a safety peek before, at, or after 130, 130 number is no longer firm another cf site to open soon in boston trauma trial drug "shipped and ready" anca theory is valid liver trial ended at about 40, and results being gathered hu1124 (imo) going better than expected after rough start mycoprex still moving towards ind iprex still in testing & review with potential partners, IMO enhanced formula is desireable &. bactericidal. This should keep the thread talkng for a while As usual, value all I say as worthless, make your own decisions, do your own research.